A new study published in the medical journal Cancer Prevention Research provides further evidence that supplements containing green tea catechins may help reduce the incidence of prostate cancer. In a randomized placebo controlled trial, men with precancerous lesions in their prostates took capsules containing 400 mg of the green tea extract epigallocatechin-3-gallate (EGCG) per day or a placebo. Carried out over a period of one year, the study found that the men who took EGCG experienced a significant decrease in levels of the cancer biomarker prostate-specific antigen (PSA). This is important as when assessed in combination with other key risk factors, high levels of PSA can indicate an increased risk of prostate cancer.
The study builds on well over a decade of research conducted at the Dr. Rath Research Institute under the direction of Dr. Aleksandra Niedzwiecki, which has repeatedly shown that EGCG has multifaceted actions in cancer prevention and carcinogenesis. A potent antioxidant and anti-inflammatory phytonutrient, EGCG works in synergy with other micronutrients such as vitamin C, lysine and proline in simultaneously controlling multiple mechanisms in cancer growth and spread. Research carried out at the Institute has proven that a micronutrient synergy combination containing EGCG is effective in preventing cancer metastasis by inhibiting the action of collagen digesting enzymes and, in addition, the growth of new blood vessels to the tumor (anti-angiogenesis).
With the global burden of cancer in 2013 comprising 14.9 million new cases worldwide, 8.2 million deaths and 196.3 million years of healthy life lost, the need to shift to a new preventive healthcare system, based on nutritional and Cellular Medicine, is clearly a matter of the highest priority. Global spending on cancer drugs now exceeds $100 billion per year, thus demonstrating that the Pharma Cartel has no interest in finding a cure for this disease. With cancer now the biggest source of income for drug makers, anything that successfully treats its root causes would destroy the financial viability of the “business with disease”.
While diseases in general are openly and ruthlessly being exploited by the pharmaceutical industry as markets for patented drugs, in the case of cancer an additional, particularly appalling, aspect deserves consideration. The diagnosis of ‘cancer’ has deliberately been portrayed as a ‘death sentence’ to the people of the world. This was not by accident. The fear of death makes millions of cancer patients accept literally ANY medical procedure – however questionable or dangerous it may be – including the highly toxic, and profitable, treatment known as “chemotherapy”.
Thus, in order for millions of lives to be saved it is first necessary to break mankind’s psychological dependency on the pharmaceutical industry’s business with cancer. Educating people that Victory Over Cancer is possible, naturally, without drugs, is a key step towards this. The sooner more of us realize it and get active, the sooner cancers of the prostate and other organs can become a thing of the past.